NCT02756091Recruiting
International Intracranial Dissection Study
International Intracranial Artery Dissection Study
Source: ClinicalTrials.gov · Last updated 13 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Cervicocerebral artery dissection is a major cause for stroke in young adults. While knowledge of cervical artery dissection (CeAD) has increased thanks to a number of high quality studies, knowledge on intracranial artery dissection (IAD) is limited. Due to treatment and publication bias little is known about the natural history of IAD. Overall, IAD is assumed to have a more severe course than CeAD, with a more ominous outcome in patients with subarachnoid hemorrhage (SAH). Furthermore, little information is available on the risk of recurrent IAD as well as on the risk of recurrent ischemic and haemorrhagic events in non-Asian patients. Radiological diagnosis of IAD can be challenging given the small size of intracranial arteries, and the subtle and non-specific radiological signs which tend to evolve over time. The optimal treatment of IAD is unknown. There are no randomised trials and only observational studies with relatively small sample sizes are available, thus providing a very low level of evidence. Finding the factors that are decisive for outcome and recurrence after intracranial artery dissection is key to an improved management of this potentially severe disease predominantly affecting young patients. By using standardised protocols for diagnosis, imaging and follow-up, the investigators intend to obtain large representative patient samples in order to fill the gap of evidence.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 11 Apr 2016
- Start date
- Aug 2016
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Diseases
- Stroke
- NCT number
- NCT02756091
What you commit to
- Study type: Observational
- Planned participants: 500
- From Aug 2016 to the primary completion date, 30 Nov 2026
- 3 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Iatrogenic dissection caused by endovascular intervention
- Extracranial dissection with intracranial extension
Who the study is looking for
- Patients with acute Intracranial Artery Dissection (symptom onset ≤ 30 days)
- Age ≥ 18 years
- Consent to participate according to local requirements
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Neurology, University Hospital Basel Coordinator of this site? Confirm its status | Basel | Switzerland | Recruiting |
| Department of Neurology, Inselspital Bern Coordinator of this site? Confirm its status | Bern | Switzerland | Recruiting |
| National Cerebral and Cardiovascular Center Osaka Coordinator of this site? Confirm its status | Osaka | Japan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.